ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 996,64
0,49%
Dow Jones
38 852,27
0,46%
DAX
18 175,21
1,01%
Brent Oil
83,455
-0,02%
Bitcoin
63 655,54
0,77%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Rani Therapeutics Holdings Inc (RANI)

  7. Rani Therapeutics Holdings Inc (RANI) Actualités

RANI Rani Therapeutics Holdings Inc

7,72
0,57 (7,97%)
07 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Rani Therapeutics Holdings Inc RANI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,57 7,97% 7,72 00:11:53
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
7,08 6,90 7,7199 7,56 7,15
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/5/202422:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202422:05GLOBERani Therapeutics Reports First Quarter 2024 Financial..
06/5/202422:04EDGAR2Form 8-K - Current report
20/3/202421:05GLOBERani Therapeutics Reports Fourth Quarter and Full Year 2023..
15/3/202421:05GLOBERani Therapeutics to Report Fourth Quarter and Full Year..
05/2/202414:10EDGAR2Form 8-K - Current report
05/2/202414:00GLOBERani Therapeutics Announces Positive Topline Results from..
19/12/202322:06EDGAR2Form 8-K - Current report
19/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202314:05EDGAR2Form 8-K - Current report
14/12/202314:00GLOBERani Therapeutics Announces Preclinical Pharmacodynamic Data..
07/12/202323:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:10EDGAR2Form 8-K - Current report
08/11/202322:05GLOBERani Therapeutics Reports Third Quarter 2023 Financial..
01/11/202321:05GLOBERani Therapeutics Announces Strategic Program..
01/11/202321:04EDGAR2Form 8-K - Current report
25/10/202314:03EDGAR2Form 8-K - Current report
25/10/202314:00GLOBEThe RaniPill® Capsule, Rani Therapeutics’ Oral Delivery..
19/10/202322:05GLOBERani Therapeutics Announces Successful Oral Delivery of..
12/10/202322:05GLOBERani Therapeutics to Present Abstract on RT-102 at the 2023..
18/9/202314:00GLOBERani Therapeutics Initiates Phase 1 Study of RT-111..
07/9/202323:04EDGAR2Form 8-K - Current report
07/9/202322:05GLOBERani Therapeutics Announces Successful Drug Delivery of..
06/9/202314:00GLOBERani Therapeutics to Participate in September Investor..
11/8/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202322:05GLOBERani Therapeutics Reports Second Quarter 2023 Financial..
08/8/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/8/202322:05GLOBERani Therapeutics to Participate in August Investor..
21/6/202314:00GLOBERani Therapeutics’ Presentation On Oral Delivery of PTH for..
08/6/202314:00GLOBERani Therapeutics Announces Acceptance of Late-Breaking..
05/6/202314:00GLOBERani Therapeutics and Celltrion Expand Partnership to..
01/6/202314:00GLOBERani Therapeutics to Present at the Jefferies Healthcare..
31/5/202314:00GLOBERani Therapeutics Announces Acceptance of Three Abstracts..
24/5/202314:00GLOBERani Therapeutics Appoints Kate McKinley as Chief Business..
10/5/202322:05GLOBERani Therapeutics Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

NASDAQ
RANI
Rani Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés